Tobacco Alkaloid Assessment in a DSS-Induced Colitis Mouse Model with a Fully Humanized Immune System

Inflammatory bowel disease (IBD) refers to chronic intestinal immune-mediated diseases including two main disease manifestations: ulcerative colitis (UC) and Crohn’s disease (CD). Epidemiological, clinical, and preclinical evidence has highlighted the potential anti-inflammatory properties of natura...

Full description

Bibliographic Details
Main Authors: Catherine Verhaeghe, Marja Talikka, Alain Sewer, Nicolas Sierro, Mehdi Auberson, Dariusz Peric, David Bornand, Remi Dulize, Emmanuel Guedj, Patrick Nef, Sebastien P. Tabruyn, Julia Hoeng, Manuel C. Peitsch, Giuseppe Lo Sasso
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/7/6419
_version_ 1797607825907646464
author Catherine Verhaeghe
Marja Talikka
Alain Sewer
Nicolas Sierro
Mehdi Auberson
Dariusz Peric
David Bornand
Remi Dulize
Emmanuel Guedj
Patrick Nef
Sebastien P. Tabruyn
Julia Hoeng
Manuel C. Peitsch
Giuseppe Lo Sasso
author_facet Catherine Verhaeghe
Marja Talikka
Alain Sewer
Nicolas Sierro
Mehdi Auberson
Dariusz Peric
David Bornand
Remi Dulize
Emmanuel Guedj
Patrick Nef
Sebastien P. Tabruyn
Julia Hoeng
Manuel C. Peitsch
Giuseppe Lo Sasso
author_sort Catherine Verhaeghe
collection DOAJ
description Inflammatory bowel disease (IBD) refers to chronic intestinal immune-mediated diseases including two main disease manifestations: ulcerative colitis (UC) and Crohn’s disease (CD). Epidemiological, clinical, and preclinical evidence has highlighted the potential anti-inflammatory properties of naturally occurring alkaloids. In the present study, we investigated the potential anti-inflammatory activities of the tobacco alkaloids nicotine and anatabine in a dextran sulfate sodium (DSS)-induced UC mouse model with a fully humanized immune system. Our results show that nicotine significantly reduced all acute colitis symptoms and improved colitis-specific endpoints, including histopathologically assessed colon inflammation, tissue damage, and mononuclear cell infiltration. The tobacco alkaloid anatabine showed similar effectiveness trends, although they were generally weaker or not significant. Gene expression analysis in the context of biological network models of IBD further pinpointed a possible mechanism by which nicotine attenuated DSS-induced colitis in humanized mice. The current study enables further investigation of possible molecular mechanisms by which tobacco alkaloids attenuate UC symptoms.
first_indexed 2024-03-11T05:35:08Z
format Article
id doaj.art-ad32ff372e02472dab8203d1027b10af
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T05:35:08Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-ad32ff372e02472dab8203d1027b10af2023-11-17T16:50:56ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-03-01247641910.3390/ijms24076419Tobacco Alkaloid Assessment in a DSS-Induced Colitis Mouse Model with a Fully Humanized Immune SystemCatherine Verhaeghe0Marja Talikka1Alain Sewer2Nicolas Sierro3Mehdi Auberson4Dariusz Peric5David Bornand6Remi Dulize7Emmanuel Guedj8Patrick Nef9Sebastien P. Tabruyn10Julia Hoeng11Manuel C. Peitsch12Giuseppe Lo Sasso13TransCure bioServices, Av Marie Curie 260, FR-74160 Archamps, FrancePMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000 Neuchâtel, SwitzerlandPMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000 Neuchâtel, SwitzerlandPMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000 Neuchâtel, SwitzerlandPMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000 Neuchâtel, SwitzerlandPMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000 Neuchâtel, SwitzerlandPMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000 Neuchâtel, SwitzerlandPMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000 Neuchâtel, SwitzerlandPMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000 Neuchâtel, SwitzerlandTransCure bioServices, Av Marie Curie 260, FR-74160 Archamps, FranceTransCure bioServices, Av Marie Curie 260, FR-74160 Archamps, FrancePMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000 Neuchâtel, SwitzerlandPMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000 Neuchâtel, SwitzerlandPMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000 Neuchâtel, SwitzerlandInflammatory bowel disease (IBD) refers to chronic intestinal immune-mediated diseases including two main disease manifestations: ulcerative colitis (UC) and Crohn’s disease (CD). Epidemiological, clinical, and preclinical evidence has highlighted the potential anti-inflammatory properties of naturally occurring alkaloids. In the present study, we investigated the potential anti-inflammatory activities of the tobacco alkaloids nicotine and anatabine in a dextran sulfate sodium (DSS)-induced UC mouse model with a fully humanized immune system. Our results show that nicotine significantly reduced all acute colitis symptoms and improved colitis-specific endpoints, including histopathologically assessed colon inflammation, tissue damage, and mononuclear cell infiltration. The tobacco alkaloid anatabine showed similar effectiveness trends, although they were generally weaker or not significant. Gene expression analysis in the context of biological network models of IBD further pinpointed a possible mechanism by which nicotine attenuated DSS-induced colitis in humanized mice. The current study enables further investigation of possible molecular mechanisms by which tobacco alkaloids attenuate UC symptoms.https://www.mdpi.com/1422-0067/24/7/6419ulcerative colitisalkaloidsmouse modelnicotine
spellingShingle Catherine Verhaeghe
Marja Talikka
Alain Sewer
Nicolas Sierro
Mehdi Auberson
Dariusz Peric
David Bornand
Remi Dulize
Emmanuel Guedj
Patrick Nef
Sebastien P. Tabruyn
Julia Hoeng
Manuel C. Peitsch
Giuseppe Lo Sasso
Tobacco Alkaloid Assessment in a DSS-Induced Colitis Mouse Model with a Fully Humanized Immune System
International Journal of Molecular Sciences
ulcerative colitis
alkaloids
mouse model
nicotine
title Tobacco Alkaloid Assessment in a DSS-Induced Colitis Mouse Model with a Fully Humanized Immune System
title_full Tobacco Alkaloid Assessment in a DSS-Induced Colitis Mouse Model with a Fully Humanized Immune System
title_fullStr Tobacco Alkaloid Assessment in a DSS-Induced Colitis Mouse Model with a Fully Humanized Immune System
title_full_unstemmed Tobacco Alkaloid Assessment in a DSS-Induced Colitis Mouse Model with a Fully Humanized Immune System
title_short Tobacco Alkaloid Assessment in a DSS-Induced Colitis Mouse Model with a Fully Humanized Immune System
title_sort tobacco alkaloid assessment in a dss induced colitis mouse model with a fully humanized immune system
topic ulcerative colitis
alkaloids
mouse model
nicotine
url https://www.mdpi.com/1422-0067/24/7/6419
work_keys_str_mv AT catherineverhaeghe tobaccoalkaloidassessmentinadssinducedcolitismousemodelwithafullyhumanizedimmunesystem
AT marjatalikka tobaccoalkaloidassessmentinadssinducedcolitismousemodelwithafullyhumanizedimmunesystem
AT alainsewer tobaccoalkaloidassessmentinadssinducedcolitismousemodelwithafullyhumanizedimmunesystem
AT nicolassierro tobaccoalkaloidassessmentinadssinducedcolitismousemodelwithafullyhumanizedimmunesystem
AT mehdiauberson tobaccoalkaloidassessmentinadssinducedcolitismousemodelwithafullyhumanizedimmunesystem
AT dariuszperic tobaccoalkaloidassessmentinadssinducedcolitismousemodelwithafullyhumanizedimmunesystem
AT davidbornand tobaccoalkaloidassessmentinadssinducedcolitismousemodelwithafullyhumanizedimmunesystem
AT remidulize tobaccoalkaloidassessmentinadssinducedcolitismousemodelwithafullyhumanizedimmunesystem
AT emmanuelguedj tobaccoalkaloidassessmentinadssinducedcolitismousemodelwithafullyhumanizedimmunesystem
AT patricknef tobaccoalkaloidassessmentinadssinducedcolitismousemodelwithafullyhumanizedimmunesystem
AT sebastienptabruyn tobaccoalkaloidassessmentinadssinducedcolitismousemodelwithafullyhumanizedimmunesystem
AT juliahoeng tobaccoalkaloidassessmentinadssinducedcolitismousemodelwithafullyhumanizedimmunesystem
AT manuelcpeitsch tobaccoalkaloidassessmentinadssinducedcolitismousemodelwithafullyhumanizedimmunesystem
AT giuseppelosasso tobaccoalkaloidassessmentinadssinducedcolitismousemodelwithafullyhumanizedimmunesystem